Clinical Trial Update: A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated intravenous scopolamine as an adjunct to electroconvulsive therapy for depression. The study was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression | Phase 2 | Status: TERMINATED | Results posted: 2017-04-18